Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finlay Macrae

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
United European Gastroenterology Journal|April 14, 2017
Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinomaAngelique Levert-Mignon, Michael J Bourke, Sarah J Lord, et al.
Hereditary Cancer in Clinical Practice|January 24, 2025
Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequencesPål Møller, Aysel Ahadova, Matthias Kloor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 24, 2022
Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic CohortsJonathan M Downie, Moeen Riaz, Jing Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2Annelie Liljegren, Gail Barker, Faye Elliott, et al.
Nature Reviews. Genetics|October 26, 2011
Mutation (variation) databases and registries: a rationale for coordination of effortsArleen D Auerbach, John Burn, Jean-Jacques Cassiman, et al.
Trials|September 26, 2022
The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary careSibel Saya, Lucy Boyd, Patty Chondros, et al.
Trials|March 20, 2026
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trialJennifer G McIntosh, Belinda Goodwin, Driss Ait Ouakrim, et al.
Gastroenterology|August 9, 2005
Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1Tiina E Raevaara, Mari K Korhonen, Hannes Lohi, et al.
Trials|July 16, 2021
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trialShakira Milton, Jennifer McIntosh, Finlay Macrae, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
United European Gastroenterology Journal|April 14, 2017
Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinomaAngelique Levert-Mignon, Michael J Bourke, Sarah J Lord, et al.
Hereditary Cancer in Clinical Practice|January 24, 2025
Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequencesPål Møller, Aysel Ahadova, Matthias Kloor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 24, 2022
Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic CohortsJonathan M Downie, Moeen Riaz, Jing Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2Annelie Liljegren, Gail Barker, Faye Elliott, et al.
Nature Reviews. Genetics|October 26, 2011
Mutation (variation) databases and registries: a rationale for coordination of effortsArleen D Auerbach, John Burn, Jean-Jacques Cassiman, et al.
Trials|September 26, 2022
The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary careSibel Saya, Lucy Boyd, Patty Chondros, et al.
Trials|March 20, 2026
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trialJennifer G McIntosh, Belinda Goodwin, Driss Ait Ouakrim, et al.
Gastroenterology|August 9, 2005
Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1Tiina E Raevaara, Mari K Korhonen, Hannes Lohi, et al.
Trials|July 16, 2021
An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trialShakira Milton, Jennifer McIntosh, Finlay Macrae, et al.
Public Health Research & Practice|August 7, 2019
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancersMarianne F Weber, Henry M Marshall, Nicole Rankin, et al.
Pageof 16